BioMarin Pharmaceutical Inc.

Direct answer

BioMarin Pharmaceutical Inc. is publicly traded on NASDAQ under the ticker BMRN.

BioMarin Pharmaceutical Inc. specializes in creating and bringing to market treatments for individuals suffering from severe and often fatal rare disorders and other critical medical conditions. The company currently markets several key pharmaceutical products. Among these are Vimizim, an enzyme replacement therapy targeting mucopolysaccharidosis (MPS) IV type A, a specific lysosomal storage disorder, and Naglazyme,...

Can you invest in BioMarin Pharmaceutical Inc.?

Yes. BioMarin Pharmaceutical Inc. trades publicly on NASDAQ as BMRN.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for BioMarin Pharmaceutical Inc.

Detailed equity research is provided by MarketSnap.